U.S. Physical Therapy (NYSE:USPH) Earns Market Outperform Rating from Citizens Jmp

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market outperform” rating reiterated by equities researchers at Citizens Jmp in a note issued to investors on Wednesday,Benzinga reports. They currently have a $98.00 price objective on the stock. Citizens Jmp’s price objective would indicate a potential upside of 53.97% from the company’s current price.

A number of other equities research analysts have also recently issued reports on the stock. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Barrington Research decreased their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Stock Up 1.8%

Shares of U.S. Physical Therapy stock opened at $63.65 on Wednesday. The stock has a market capitalization of $968.75 million, a P/E ratio of 127.30, a PEG ratio of 1.73 and a beta of 1.16. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41. The stock has a 50 day moving average price of $66.64 and a two-hundred day moving average price of $75.79. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The firm had revenue of $198.29 million during the quarter, compared to the consensus estimate of $200.94 million. During the same period in the prior year, the business earned $0.48 EPS. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Equities analysts expect that U.S. Physical Therapy will post 2.99 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Peter Francis Minan purchased 492 shares of the stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the purchase, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.40% of the stock is currently owned by company insiders.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently modified their holdings of the company. Hantz Financial Services Inc. raised its stake in shares of U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares in the last quarter. Advisory Services Network LLC bought a new stake in U.S. Physical Therapy in the 3rd quarter valued at $39,000. EverSource Wealth Advisors LLC increased its holdings in U.S. Physical Therapy by 68.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after buying an additional 192 shares during the period. GAMMA Investing LLC raised its stake in shares of U.S. Physical Therapy by 207.1% in the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after buying an additional 348 shares in the last quarter. Finally, iSAM Funds UK Ltd acquired a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at $52,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.